GlaxoSmithKline Pharmaceuticals Ltd.

BSE: 500660 | NSE: GLAXO |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE159A01016 | SECTOR: PharmaceuticalsPharmaceuticals

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

GlaxoSmithKlin GlaxoSmithKline Pharmaceuticals Ltd. | BSE 1454.50 8.70 (0.60%) | NSE 1455.15 9.10 (0.63%) | Trade | Add

BSE Live

Apr 12, 16:00

1454.50 8.70 (0.60%)

Volume

AVERAGE VOLUME

5-Day

1,932

10-Day

2,497

30-Day

3,929

4,086

Prev. Close

1445.80
Open Price

1465.00

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Apr 12, 15:57

1455.15 9.10 (0.63%)

Volume

AVERAGE VOLUME

5-Day

58,072

10-Day

45,263

30-Day

45,869

70,780

Prev. Close

1446.05
Open Price

1444.00

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
1455.15 (34)

Financials

Download Annual Report in PDF format 2020 2019 2018 2017 2016

Print/Copy to Excel : Go

Profit & Loss account of GlaxoSmithKline Pharmaceuticals (in Rs. Cr.)	Mar 20	Mar 19	Mar 18	Mar 17	Mar 16
	12 mths	12 mths	12 mths	12 mths	12 mths
INCOME
Revenue From Operations [Gross]	3,187.35	3,089.48	2,820.03	2,920.79	2,753.02
Less: Excise/Sevice Tax/Other Levies	0.00	0.00	24.19	91.52	91.03
Revenue From Operations [Net]	3,187.35	3,089.48	2,795.84	2,829.27	2,662.00
Total Operating Revenues	3,224.68	3,128.53	2,871.69	2,902.99	2,735.19
Other Income	77.56	101.48	53.52	72.01	121.83
Total Revenue	3,302.24	3,230.01	2,925.21	2,975.00	2,857.01
EXPENSES
Cost Of Materials Consumed	474.38	682.07	510.27	523.58	632.17
Operating And Direct Expenses	0.00	0.00	0.00	0.00	0.00
Changes In Inventories Of FG,WIP And Stock-In Trade	-35.43	25.57	-57.94	79.49	-144.49
Employee Benefit Expenses	628.55	537.20	523.40	483.01	443.37
Finance Costs	6.34	0.55	0.19	0.25	0.00
Depreciation And Amortisation Expenses	82.68	48.59	37.99	26.35	24.95
Other Expenses	629.81	631.33	599.10	606.27	587.44
Total Expenses	2,655.24	2,571.20	2,401.42	2,509.65	2,283.38
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	646.99	658.82	523.79	465.35	573.63
Exceptional Items	-324.49	4.89	17.80	45.73	2.31
Profit/Loss Before Tax	322.50	663.71	541.58	511.08	575.94
Tax Expenses-Continued Operations
Current Tax	235.31	192.82	204.34	162.97	207.49
Less: MAT Credit Entitlement	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-47.72	45.52	-14.74	11.33	-6.08
Tax For Earlier Years	24.86	0.00	0.00	0.00	0.00
Total Tax Expenses	212.45	238.35	189.60	174.30	201.41
Profit/Loss After Tax And Before ExtraOrdinary Items	110.05	425.36	351.99	336.78	374.53
Profit/Loss From Continuing Operations	110.05	425.36	351.99	336.78	374.53
Profit/Loss For The Period	110.05	425.36	351.99	336.78	374.53
OTHER ADDITIONAL INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)	6.50	25.11	41.56	39.76	44.22
Diluted EPS (Rs.)	6.50	25.11	41.56	39.76	44.22
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS
Imported Raw Materials	0.00	0.00	0.00	0.00	69.17
Indigenous Raw Materials	0.00	0.00	0.00	0.00	567.80
STORES, SPARES AND LOOSE TOOLS
Imported Stores And Spares	0.00	0.00	0.00	0.00	0.00
Indigenous Stores And Spares	0.00	0.00	0.00	0.00	0.00
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	338.81	296.46	254.11	423.52	529.39
Tax On Dividend	69.64	60.94	51.73	86.22	107.77
Equity Dividend Rate (%)	400.00	200.00	350.00	300.00	500.00